
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+8
NGeneBio Co., Ltd. is a leading company in molecular diagnostics (MDx) and companion diagnostics (CDx), which develops and provides next generation sequencing (NGS)-based in vitro diagnostics (IVD) panel and clinical analysis software (SW). NGeneBio was founded in October 2015, headquartered in Seoul, South Korea as a joint venture between Genecurix and Korea Telecom. The company launched NGS-based hereditary breast/ovarian cancer panel (BRCAaccuTestTM) with clinical analysis SW (NGeneAnalysisTM) in 2016. BRCA NGS panel for PARP inhibitor CDx test and solid tumor/hematologic cancer NGS panels will be launched, inclusive of clinical data analysis SW platform. The mission of the company is to...
Next generation sequencing (ngs),clinical ngs,molecular diagnostics (mdx),ngs analysis software,in vitro diagnostics (ivd),companion diagnostics (cdx),brcaaccutest,ngeneanalysys,ngs ivd,cancer diagnostics,medical device,diagnostics,and genetic testing
Ngenebio co., ltd operates in the Medical equipment manufacturing industry.
Ngenebio co., ltd's revenue is 1m - 10m
Ngenebio co., ltd has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.